Pharmacological treatment and current controversies in COPD
Keyword(s):
Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and this is due in part to our current inability to discover new drugs capable of decisively influencing the course of the disease. However, in recent years, information has been produced that, if used correctly, can allow us to improve the use of the available therapies.
2021 ◽
Vol 203
(1)
◽
pp. 24-36
◽
2018 ◽
Vol 197
(5)
◽
pp. 670-673
◽
2002 ◽
Vol 8
(2)
◽
pp. 81-86
◽
2019 ◽
Vol 16
(1)
◽
pp. 29-39
◽
2017 ◽
Vol 15
(1)
◽
pp. 21-26
◽
2019 ◽
Vol 16
(2)
◽
pp. 200-208
◽